-
1.
公开(公告)号:EP4461745A1
公开(公告)日:2024-11-13
申请号:EP22919084.8
申请日:2022-12-27
发明人: CHUNG, Eu Ddeum , RYU, Soomin , KIM, Donggeon , CHANG, Jihoon , LEE, Byoung Chul
摘要: The present invention relates to a fusion protein comprising an anti-C3b antibody or an anti-C5 antibody and an angiogenesis inhibitor, and a composition for treating eye diseases, particularly macular degeneration, by using the same. The protein may not only inhibit complement-related pathways, but can also efficiently regulate angiogenesis. Therefore, the fusion protein dimer can be effectively used to treat and prevent complement-related diseases, particularly eye diseases such as macular degeneration, and thus has high industrial applicability.
-
公开(公告)号:EP4458862A1
公开(公告)日:2024-11-06
申请号:EP21969269.6
申请日:2021-12-27
发明人: XU, Jianqing , ZHANG, Xiaoyan , DING, Xiangqing , LIAO, Qibin , WANG, Shiyu , ZHOU, Junhua
IPC分类号: C07K19/00 , C12N7/01 , C12N15/62 , C12N15/863 , A61K35/76 , A61K35/768 , A61K39/395 , A61P35/00
摘要: Provided by the present invention are a bispecific T-cell engager, recombinant oncolytic virus thereof, and use thereof. The present invention provides an αCD47 and αCD3 bispecific T-cell engager. The present invention also provides an isolated nucleic acid molecule that encodes said bispecific T-cell engager. The present invention also provides an expression framework of said bispecific T-cell engager BiTE. The present invention also provides a recombinant oncolytic virus, and said oncolytic virus is operably inserted with or contains the expression framework of said bispecific T-cell engager BiTE. In the present invention, the bispecific T-cell engager is combined with the oncolytic virus, and in comparison with pure gene therapy or virotherapy, the oncolytic virus significantly enhances the inhibition capability on malignant tumors.
-
公开(公告)号:EP4457346A1
公开(公告)日:2024-11-06
申请号:EP22915046.1
申请日:2022-12-29
发明人: YANG, Liu , JIANG, Wenqing , FANG, Lei
-
公开(公告)号:EP4455277A1
公开(公告)日:2024-10-30
申请号:EP22912059.7
申请日:2022-12-26
申请人: Samyang Corporation
发明人: KO, Hyeokjin , MOON, Junho , KIM, Jeongmin , KIM, Min Young , PARK, Busoo
摘要: The present disclosure relates to a composition for producing steviol glycosides containing Rebaudioside M at high purity, using a biocatalyst containing UDP-glycosyltransferase and UGT76G1, and a method for producing steviol glycosides using the same.
-
公开(公告)号:EP4453193A1
公开(公告)日:2024-10-30
申请号:EP22854444.1
申请日:2022-12-22
-
公开(公告)号:EP4453030A1
公开(公告)日:2024-10-30
申请号:EP22910231.4
申请日:2022-12-23
申请人: Inmagene Pte. Ltd.
发明人: LEI, Run , GUO, Chongtian , FAN, Pengcheng , XU, Zhihao , SUN, Qiang , WANG, Jonathan Jian
IPC分类号: C07K16/24 , C07K16/46 , C12N15/13 , C12N15/62 , C12N15/64 , C12N15/85 , C12N5/0783 , A61K39/395 , A61P37/00 , A61P35/00
-
公开(公告)号:EP4453009A1
公开(公告)日:2024-10-30
申请号:EP22854442.5
申请日:2022-12-19
申请人: Zoetis Services LLC
IPC分类号: C07K14/11 , A61K39/145 , C12N15/62 , A61K39/155 , C07K14/115 , A61K48/00
-
公开(公告)号:EP4448770A1
公开(公告)日:2024-10-23
申请号:EP22907538.7
申请日:2022-12-16
IPC分类号: C12N15/62 , C12N15/50 , A61K39/215 , A61P31/14 , C07K14/165
-
公开(公告)号:EP4444759A1
公开(公告)日:2024-10-16
申请号:EP22903554.8
申请日:2022-12-08
发明人: QIN, Gang , SONG, Paul H. , YANG, Dong , LV, Cao
-
公开(公告)号:EP3959232B1
公开(公告)日:2024-10-16
申请号:EP20795297.9
申请日:2020-04-23
IPC分类号: C07K14/705 , C07K16/08 , C07K19/00 , C12N15/62
-
-
-
-
-
-
-
-
-